UltraTech Cement Limited (ULTRACEMCO) Revenue 2022–2026

Name: UltraTech Cement Limited (ULTRACEMCO) revenue history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

UltraTech Cement Limited annual revenue for fiscal 2026 was ₹873.8 billion, an increase of 16.6% from ₹749.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

ULTRACEMCO Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹873.8B	₹749.4B	₹698.1B	₹623.4B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ULTRACEMCO Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹246.5B	₹258.0B	₹218.3B	₹212.8B	₹230.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

GRASIM Revenue — Grasim Industries Limited
AMBUJACEM Revenue — Ambuja Cements Limited
SHREECEM Revenue — Shree Cement Limited
5233 Revenue — Taiheiyo Cement Corporation
JKCEMENT Revenue — J.K. Cement Limited
DALBHARAT Revenue — Dalmia Bharat Limited

More ULTRACEMCO metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All ULTRACEMCO financial statements → Interactive ULTRACEMCO charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.